Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.

Helle Pedersen, Nils Brünner, Deanne Francis et al. · PubMed · 1994 · 290 citations

Medicine, Oncology, Cancer Immunology +14

Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

Ross W. Stephens · JNCI Journal of the National Cancer Institute · 1999 · 280 citations

Medicine, Cancer Biology, Oncology +16

Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain.

Gunilla Høyer‐Hansen, Ebbe Rønne, Helene Solberg et al. · Journal of Biological Chemistry · 1992 · 253 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +10

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma

Domingo Cantero, J. Deflorin, A. Zimmermann et al. · British Journal of Cancer · 1997 · 208 citations

Medicine, Cancer Biology, Oncology +11

The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients.

Cornelis F.M. Sier, Ross W. Stephens, Jozef Bízik et al. · PubMed · 1998 · 192 citations

Medicine, Gynecology, Oncology +15